June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Human trabecular meshwork stem cell derived exosomes enhanced wound healing and antioxidant property: an attempt towards a cell-free therapy for glaucoma
Author Affiliations & Notes
  • Radhakrishnan Iswarya
    Immunology and Stem Cell Biology, Aravind Medical Research Foundation, Madurai, Tamil Nadu, India
  • Krishnadas Subbaiah
    Glaucoma, Aravind Eye Hospital, Madurai, Tamil Nadu, India
  • Veerappan Muthukkaruppan
    Immunology and Stem Cell Biology, Aravind Medical Research Foundation, Madurai, Tamil Nadu, India
  • Dharmalingam Kuppamuthu
    Proteomics, Aravind Medical Research Foundation, Madurai, Tamil Nadu, India
  • Chidambaranathan Gowri Priya
    Immunology and Stem Cell Biology, Aravind Medical Research Foundation, Madurai, Tamil Nadu, India
  • Footnotes
    Commercial Relationships   Radhakrishnan Iswarya None; Krishnadas Subbaiah None; Veerappan Muthukkaruppan None; Dharmalingam Kuppamuthu None; Chidambaranathan Gowri Priya None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 3457. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Radhakrishnan Iswarya, Krishnadas Subbaiah, Veerappan Muthukkaruppan, Dharmalingam Kuppamuthu, Chidambaranathan Gowri Priya; Human trabecular meshwork stem cell derived exosomes enhanced wound healing and antioxidant property: an attempt towards a cell-free therapy for glaucoma. Invest. Ophthalmol. Vis. Sci. 2023;64(8):3457.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To evaluate the efficacy of trabecular meshwork stem cell (SC) derived exosomes on trabecular meshwork (TM) cell survival under oxidative stress and wound healing in vitro as an attempt towards a cell free therapy for glaucoma.

Methods : Exosomes were isolated from conditioned medium of human TM and TMSC cultures by ultracentrifugation and characterized by western blotting, nanoparticle tracking analysis (NTA) using NS300 and Transmission Electron Microscopy (TEM). Regenerative efficacy of the isolated exosomes was analyzed by in vitro wound healing assay. Anti-oxidant role of exosomes on TM cells exposed to oxidative stress was examined by MTT assay. TM and TMSC exosomes were also subjected to mass spectrometry to identify the protein cargo.

Results : TM and TMSC exosomes expressed the exosomal markers syntenin, neuropilin and emilin. NTA analysis revealed the size of TM (150.7±20.03nm) and TMSC (137.7±11.9nm) exosomes to be within exosomal size range of 30-200nm. TEM images revealed the exosomes to be poly-dispersive and spherical in nature. In vitro wound healing assay indicated that the TMSC exosomes significantly increased the wound closure rate (96.47±2.95%) compared to control (75.80±4.62%) at 48 hours. In addition, the TMSC exosomes enhanced TM cell survival by 21.9% under oxidative stress compared to TM exosomes. Proteomic analysis of exosomes identified with high confidence 720 proteins in TMSC exosomes and 693 in TM exosomes. 43.3% of the proteins were common between TM and TMSC exosomes while 30.9% proteins were only found in TMSC exosomes and 25.8% proteins only in TM exosomes. Differential expression analysis showed high abundance of wound healing and anti-oxidant proteins in TMSC exosomes compared to TM exosomes.

Conclusions : TMSC exosomes enhanced wound healing efficacy and their anti-oxidant potential indicating the possibility of developing a TMSC exosome based therapy for patients with primary open angle glaucoma.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×